BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9454572)

  • 1. P-glycoprotein shows strong catalytic cooperativity between the two nucleotide sites.
    Senior AE; Bhagat S
    Biochemistry; 1998 Jan; 37(3):831-6. PubMed ID: 9454572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic mechanism of P-glycoprotein.
    Senior AE
    Acta Physiol Scand Suppl; 1998 Aug; 643():213-8. PubMed ID: 9789563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway.
    Tombline G; Muharemagić A; White LB; Senior AE
    Biochemistry; 2005 Sep; 44(38):12879-86. PubMed ID: 16171403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
    Qu Q; Russell PL; Sharom FJ
    Biochemistry; 2003 Feb; 42(4):1170-7. PubMed ID: 12549939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug binding and nucleotide hydrolyzability are essential requirements in the vanadate-induced inhibition of the human P-glycoprotein ATPase.
    Rao US
    Biochemistry; 1998 Oct; 37(42):14981-8. PubMed ID: 9778376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximity of the nucleotide binding domains of the P-glycoprotein multidrug transporter to the membrane surface: a resonance energy transfer study.
    Liu R; Sharom FJ
    Biochemistry; 1998 May; 37(18):6503-12. PubMed ID: 9572868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains.
    Liu R; Sharom FJ
    Biochemistry; 1996 Sep; 35(36):11865-73. PubMed ID: 8794769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both P-glycoprotein nucleotide-binding sites are catalytically active.
    Urbatsch IL; Sankaran B; Bhagat S; Senior AE
    J Biol Chem; 1995 Nov; 270(45):26956-61. PubMed ID: 7592942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of P-glycoprotein ATPase activity by procedures involving trapping of nucleotide in catalytic sites.
    Sankaran B; Bhagat S; Senior AE
    Arch Biochem Biophys; 1997 May; 341(1):160-9. PubMed ID: 9143365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state.
    Ramachandra M; Ambudkar SV; Chen D; Hrycyna CA; Dey S; Gottesman MM; Pastan I
    Biochemistry; 1998 Apr; 37(14):5010-9. PubMed ID: 9538020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residues in P-glycoprotein catalytic sites that react with the inhibitor 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole.
    Senior AE; Gros P; Urbatsch IL
    Arch Biochem Biophys; 1998 Sep; 357(1):121-5. PubMed ID: 9721190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein is stably inhibited by vanadate-induced trapping of nucleotide at a single catalytic site.
    Urbatsch IL; Sankaran B; Weber J; Senior AE
    J Biol Chem; 1995 Aug; 270(33):19383-90. PubMed ID: 7642618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FRET analysis indicates that the two ATPase active sites of the P-glycoprotein multidrug transporter are closely associated.
    Qu Q; Sharom FJ
    Biochemistry; 2001 Feb; 40(5):1413-22. PubMed ID: 11170469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of P-glycoprotein ATPase activity by beryllium fluoride.
    Sankaran B; Bhagat S; Senior AE
    Biochemistry; 1997 Jun; 36(22):6847-53. PubMed ID: 9184168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
    Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
    Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The catalytic cycle of P-glycoprotein.
    Senior AE; al-Shawi MK; Urbatsch IL
    FEBS Lett; 1995 Dec; 377(3):285-9. PubMed ID: 8549739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in either nucleotide-binding site of P-glycoprotein (Mdr3) prevent vanadate trapping of nucleotide at both sites.
    Urbatsch IL; Beaudet L; Carrier I; Gros P
    Biochemistry; 1998 Mar; 37(13):4592-602. PubMed ID: 9521779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of protection by MgADP and MgATP of α3β3γ subcomplex of thermophilic Bacillus PS3 βY341W-mutant F1-ATPase from inhibition by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole support a bi-site mechanism of catalysis.
    Milgrom YM
    Biochemistry (Mosc); 2011 Nov; 76(11):1253-61. PubMed ID: 22117552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids.
    Eckford PD; Sharom FJ
    Biochem J; 2005 Jul; 389(Pt 2):517-26. PubMed ID: 15799713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of P-glycoprotein ATPase by analogues of tetramethylrosamine: coupling of drug binding at the "R" site to the ATP hydrolysis transition state.
    Tombline G; Donnelly DJ; Holt JJ; You Y; Ye M; Gannon MK; Nygren CL; Detty MR
    Biochemistry; 2006 Jul; 45(26):8034-47. PubMed ID: 16800628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.